Is Arm Holdings (ARM) a Good Investment? Stock Price Prediction 2027–2030 and Beyond

Arm spent 36 years as the company every chipmaker licensed technology from, never building a single chip of its own. That changed in March 2026, and weeks before this article was written, a Delaware jury found Arm breached its license agreement with one of those very licensees, leaving a bigger question still unresolved: can Qualcomm now stop paying Arm royalties entirely.

The table below shows our year-end price scenarios from 2027 through 2035, measured against ARM's recent price of $235. Unlike most other stocks in this series, our base case stays close to flat for years, reflecting how much optimism is already priced into a stock that traded above 100 times forward earnings before its recent pullback.

From IP Licensor to Chipmaker: Arm's Biggest Strategic Shift Ever

Arm's traditional business is capital-light by design. The company licenses its chip architecture and core designs to customers like Apple, Qualcomm, Nvidia and nearly every smartphone maker, collecting a royalty on every chip shipped using that design without manufacturing anything itself.

In March 2026, that changed. Arm unveiled the AGI CPU, its first self-designed, production chip, a 136-core data center processor built on TSMC's 3-nanometer process and co-developed with Meta, its first customer. On a theoretical $1,000 chip, Arm's licensing model earns roughly 5%; selling the finished silicon captures the full price instead.

The logic: hyperscalers like Amazon, Microsoft and Google already build their own Arm-based custom chips, proving the architecture works at scale while capturing most of the value themselves. CEO Rene Haas is betting Arm can capture more of that value by selling complete chips, even though it means competing with longtime partners including Nvidia, AMD and Intel.

The Qualcomm Verdict: A Live Threat to the Royalty Model

While Arm was building its chipmaking future, a long-running legal fight over its past reached a decisive moment. On October 13, 2026, a federal jury in Delaware found that Arm breached its Architecture License Agreement with Qualcomm and interfered with Qualcomm's business relationship with Meta, awarding Qualcomm a symbolic $2 in total damages across those two findings.

The dollar amount is trivial; what matters is what the breach finding leaves open.

• The five-year royalty question: The license agreement reportedly contains a clause letting Qualcomm stop paying Arm royalties for up to five years if a breach is proven, worth potentially billions. Arm argues the clause is unenforceable, and the decision now sits with Judge Maryellen Noreika in a separate bench trial not yet ruled on.
• The dispute's origin: The case traces to Qualcomm's 2021 acquisition of Nuvia, a startup founded by former Apple chip architects whose designs became Qualcomm's Snapdragon X and Oryon cores. Arm argued Qualcomm never had permission to transfer Nuvia's license.
• A split verdict: The jury sided with Qualcomm on two of six counts, the license breach and the Meta interference, while siding with Arm on the other four, including rejecting Qualcomm's pricing and good-faith claims. Both companies publicly claimed a form of victory.

Qualcomm's architecture license runs until 2033 and is unaffected by this verdict. The royalty-suspension question is still a genuine overhang, since Arm doesn't break out how much royalty revenue comes from Qualcomm, making the stakes hard to size.

Q1 Fiscal 2027: The Business Itself Keeps Compounding

Away from the courtroom, Arm's numbers remain strong. The quarter ended June 2026, reported July 29, showed record first-quarter revenue of $1.29 billion, up 22%, with non-GAAP EPS up 29% to $0.45.

• Royalty revenue: $715 million, up 22%, with data center royalties more than doubling as Neoverse-based server chips keep gaining share.
• Licensing revenue: $574 million, up 23%, reflecting strong demand for the newer Armv9 architecture, which carries a higher royalty rate.
• Margins: Non-GAAP gross margin of 98% and operating margin of 41%, reflecting the asset-light model generating most of Arm's profit today.
• A near-term wrinkle: Rising memory prices, the same dynamic driving Micron's results in this series, pushed Arm's fiscal 2027 royalty growth outlook down to the high teens from roughly 20%, with Q2 guided near 13%.

For the prior fiscal year ended March 2026, Arm delivered $4.92 billion in revenue, up 23%, its third straight year above 20% growth since going public. Management has guided royalty revenue to a 20% CAGR from fiscal 2026 through 2031, with AGI CPU revenue targeted near $15 billion by that year.

Is Arm a Good Investment? Three Pillars to Weigh

Arm's case rests on three pillars, each with a real counterweight worth understanding.

• The royalty model is exceptional, when it's not under legal threat. Royalties scale with chip shipments across nearly every smartphone and a growing share of AI data center silicon, near 100% gross margin. The Qualcomm bench-trial ruling is a real, if hard-to-size, risk to that predictability.
• The AGI CPU is a bold bet with real channel conflict. Building silicon that competes with Nvidia, AMD and Intel, Arm's own licensees, risks souring relationships generating the bulk of today's revenue, even as it opens a path to capturing far more value per chip than licensing alone could.
• The valuation already prices in a lot of success. Even after its October pullback, ARM trades at a rich multiple of forward earnings, among the richest in this series, leaving little room for the Qualcomm ruling or the AGI CPU launch to disappoint.

The balance sheet is solid, supported by Arm's capital-light model and majority owner SoftBank, though SoftBank's roughly 90% stake means a comparatively small public float, which can amplify volatility, as the stock's 2026 round trip from under $150 to above $450 and back toward $235 shows.

ARM Stock Price Prediction 2027: Waiting on a Verdict

2027 is likely defined by one event outside Arm's control: Judge Noreika's ruling on whether Qualcomm can suspend royalty payments. Our base case assumes a middling outcome, meaningful but not existential, while royalty growth recovers toward the high teens as the memory-price headwind fades.

At a 95 times multiple on EPS near $2.10, down from Arm's historically richer multiples, the base target is $205, about 13% below today's price. The $320 bull case assumes the ruling favors Arm decisively. The $120 bear case assumes Qualcomm wins the royalty-suspension question, removing a hard-to-replace slice of near-term revenue.

ARM Stock Price Prediction 2028: The AGI CPU's First Real Test

By 2028, the AGI CPU should be in its first full year of volume with Meta, plus whatever reported partners like OpenAI, Cerebras and Cloudflare have moved from pilots to real orders. Our base case assumes this segment adds meaningfully to revenue but stays margin-dilutive next to core licensing.

At an 80 times multiple on EPS near $2.60, the base target is $215, still about 9% below today's price. The $420 bull case assumes AGI CPU adoption broadens quickly without damaging Arm's licensee relationships. The $100 bear case assumes the chip struggles beyond Meta, while legal costs and the Qualcomm overhang keep weighing on sentiment.

ARM Stock Price Prediction 2030: Does the Multiple Finally Make Sense?

By 2030, fiscal 2031, the year Arm's own targets point to, should be in close sight: a 20% royalty CAGR and roughly $15 billion in AGI CPU revenue. Our base case assumes Arm tracks close to, though not quite at, those self-set targets, with non-GAAP EPS near $3.90.

At a 58 times multiple, reflecting a business maturing but still growing faster than most large-cap peers, the base target is $235, essentially flat. That flatness is the central message of our model: Arm's stock already encodes enormous optimism, and even solid execution against management's own targets may only justify today's price, not exceed it.

The $620 bull case assumes Arm hits or beats its fiscal 2031 targets while the market keeps paying a premium multiple. The $125 bear case assumes the AGI CPU never scales beyond Meta and legal costs from an appealed Qualcomm ruling drag on for years.

2031 to 2035: A Decade to Grow Into the Price

Beyond 2030, our model assumes Arm settles into steadier growth as both halves of its business, licensing and silicon, mature, with the valuation multiple compressing gradually even as earnings keep growing at a respectable, if no longer explosive, pace.

The base-case milestones for the back half of our forecast:

• 2031 and 2032 ($245 and $255): AGI CPU revenue approaches management's roughly $15 billion fiscal 2031 target, while its margin profile becomes clearer to investors.
• 2033 and 2034 ($265 and $275): The smartphone royalty base, Arm's original business, matures into steady, lower-growth cash generation alongside faster-growing data center royalties.
• 2035 ($285): A roughly 34 times multiple on EPS near $7.50, a level still rich by typical hardware standards but far below where ARM traded through much of 2026.

The $880 bull target for 2035 assumes Arm becomes a genuine third force in data center silicon alongside Nvidia and AMD, with its royalty base compounding at its targeted rate. The $200 bear target assumes the chipmaking pivot never escapes Meta-sized scale and legal costs recur across other licensees over the decade.

Bull Case vs. Bear Case: What Could Go Right and What Could Break

These are the clearest paths toward our bull scenarios.

• Bull Catalyst 1, a favorable or moot royalty ruling. A decision that leaves Arm's royalty stream intact, or a settlement that resolves the dispute before Judge Noreika rules, would remove the single biggest near-term overhang on the stock.
• Bull Catalyst 2, AGI CPU customers beyond Meta materialize. Reported launch partners including OpenAI, Cerebras and Cloudflare converting to real deployments would validate the chipmaking pivot without Arm needing to win over its biggest former GPU and CPU partners.
• Bull Catalyst 3, data center royalty momentum continues. With data center royalties more than doubling year over year and Neoverse core shipments compounding, this segment alone could keep driving royalty growth back toward 20% even without the silicon business.

These are the risks most likely to pull the stock toward our bear scenarios.

• Bear Risk 1, the royalty-suspension ruling goes against Arm. A ruling that lets Qualcomm withhold royalty payments for up to five years would hit a business model built entirely around predictable, recurring royalty income, and could embolden other licensees in future disputes.
• Bear Risk 2, channel conflict damages the core licensing business. Nvidia, AMD, Intel and other AGI CPU competitors are also major Arm licensees. If any meaningfully reduces its reliance on Arm technology in response, the licensing business that funds everything else would suffer.
• Bear Risk 3, the valuation simply has no room for error. Trading at one of the richest multiples in this series even after a sharp pullback, ARM is unusually exposed to any combination of legal, competitive or execution disappointment.

The Verdict: Who Should Own Arm, and Who Should Wait

Arm suits investors who believe in both halves of its strategy, a durable royalty model and a credible new silicon business, and who can tolerate real legal uncertainty over a core part of the investment case. The stock's volatility in 2026 alone, from under $150 to above $450 and back toward $235, shows this isn't a stock for anyone seeking stability.

It is a poor fit for value-focused investors or anyone uncomfortable holding through an unresolved court ruling that could hit near-term cash flow. Investors who already hold Qualcomm, Nvidia, AMD or Intel should note Arm's new chip business puts it in more direct competition with each of them.

For sizing, we think 1% to 3% of liquid assets is a sensible ceiling, smaller than our ranges for more established names in this series, given the rich valuation and unresolved legal risk.

Frequently Asked Questions

These are the questions we hear most often about Arm's royalty model, the Qualcomm case and its chipmaking pivot.

Sources and Reference Materials

The data in this analysis comes from Arm's SEC filings and earnings materials, cross-checked against reputable financial and legal coverage and market data current at the time of writing.

• SEC EDGAR: Arm Holdings plc First Quarter Fiscal 2027 Results (Form 6-K)
• SEC EDGAR: Arm Holdings plc Fourth Quarter and Fiscal Year 2026 Results (Form 6-K)
• Reuters via The Star: Qualcomm Says Jury Found Arm Breached License Agreement
• TechCrunch: Arm Is Releasing the First In-House Chip in Its 35-Year History
• Yahoo Finance: Arm Holdings Stock Closed Above Wall Street's $289 Target
• StockTitan: Arm Holdings (ARM) Stock Price, News & Analysis

This article is for informational purposes only and is not financial advice. Price targets are CoinDecimal model scenarios based on public data available at the time of writing, and actual results may differ materially.